Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA.
Department of Neurology, Washington University School of Medicine, 660 S Euclid Avenue, Campus Box 8111, St. Louis, MO, USA; Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA.
J Stroke Cerebrovasc Dis. 2024 Oct;33(10):107913. doi: 10.1016/j.jstrokecerebrovasdis.2024.107913. Epub 2024 Aug 3.
Hemorrhagic transformation (HT) and cerebral edema (CED) are both major complications following ischemic stroke, but few studies have evaluated their overlap. We evaluated the frequency and predictors of CED/HT overlap and whether their co-occurrence impacts functional outcome more than each in isolation.
892 stroke patients enrolled in a prospective study had follow-up CT imaging evaluated for HT and CED; the latter was quantified using the ratio of hemispheric CSF volumes (with hemispheric CSF ratio < 0.90 used as the CED threshold). The interaction between HT and CED on functional outcome (using modified Rankin Scale at 3 months) was compared to that for each condition separately.
Among the 275 (31%) who developed HT, 233 (85%) manifested hemispheric CSF ratio < 0.9 (CED/HT), with this overlap group representing half of the 475 with measurable CED. Higher baseline NIHSS scores and larger infarct volumes were observed in the CED/HT group compared with those with CED or HT alone. Functional outcome was worse in those with CED/HT [median mRS 3 (IQR 2-5)] than those with CED [median 2 (IQR 1-4)] or HT alone [median 1 (IQR 0-2), p < 0.0001]. Overlap of CED/HT independently predicted worse outcome [OR 1.89 (95% CI: 1.12-3.18), p = 0.02] while HT did not; however, CED/HT was no longer associated with worse outcome after adjusting for severity of CED [adjusted OR 0.35 (95% CI: 0.23, 0.51) per 0.21 lower hemispheric CSF ratio, p < 0.001].
Most stroke patients with HT also have measurable CED. The co-occurrence of CED and HT occurs in larger and more severe strokes and is associated with worse functional outcome, although this is driven by greater severity of stroke-related edema in those with HT.
出血性转化(HT)和脑水肿(CED)都是缺血性卒中后的主要并发症,但很少有研究评估它们的重叠情况。我们评估了 CED/HT 重叠的频率和预测因素,以及它们的共同发生是否比各自孤立发生对功能结局的影响更大。
892 例接受前瞻性研究的卒中患者进行了随访 CT 成像评估,以评估 HT 和 CED;后者使用半球 CSF 容积比(使用半球 CSF 比 < 0.90 作为 CED 阈值)进行量化。HT 和 CED 对功能结局(3 个月时使用改良 Rankin 量表)的相互作用与每种情况分别进行比较。
在 275 例(31%)发生 HT 的患者中,233 例(85%)表现出半球 CSF 比 < 0.9(CED/HT),重叠组占可测量 CED 的 475 例的一半。与单独发生 CED 或 HT 的患者相比,CED/HT 组的基线 NIHSS 评分和梗死体积较大。CED/HT 患者的功能结局较差[中位数 mRS 3(IQR 2-5)],CED 患者[中位数 2(IQR 1-4)]或 HT 患者[中位数 1(IQR 0-2)]较差(p < 0.0001)。CED/HT 的重叠独立预测预后较差[OR 1.89(95%CI:1.12-3.18),p = 0.02],而 HT 则没有;然而,在调整 CED 严重程度后,CED/HT 与预后较差不再相关[每降低 0.21 的半球 CSF 比,调整后的 OR 0.35(95%CI:0.23,0.51),p < 0.001]。
大多数发生 HT 的卒中患者也有可测量的 CED。CED 和 HT 的同时发生发生在更大和更严重的中风中,与更差的功能结局相关,尽管这是由 HT 患者中风相关水肿的严重程度驱动的。